Novel inflammatory markers of coronary risk: theory versus practice.

@article{Libby1999NovelIM,
  title={Novel inflammatory markers of coronary risk: theory versus practice.},
  author={Patricia J. Libby and Paul M. Ridker},
  journal={Circulation},
  year={1999},
  volume={100 11},
  pages={
          1148-50
        }
}
For practitioners committed to coronary risk reduction, recent clinical trial data pose a considerable challenge. Specifically, in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS), a primary prevention trial, 1 treatment with lovastatin among an apparently healthy group of individuals without traditional coronary risk factors resulted in significant reductions in future cardiovascular events. Application of the results of that trial and of the West of Scotland… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Explore Further: Topics Discussed in This Paper

Citations

Publications citing this paper.
SHOWING 1-10 OF 163 CITATIONS

FILTER CITATIONS BY YEAR

2000
2019

CITATION STATISTICS

  • 8 Highly Influenced Citations

  • Averaged 7 Citations per year over the last 3 years

References

Publications referenced by this paper.
SHOWING 1-10 OF 26 REFERENCES

Association of serum antibodies to heatshock protein 65 with carotid atherosclerosis : clinical significance determined in a follow - up study

  • PM Ridker, M Cushman, MJ Stampfer, RP Tracy, CH Hennekens
  • Circulation
  • 1999

C - reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

  • Hwang S-J, CM Ballantyne, +4 authors E Boerwinkle
  • Circulation
  • 1998

Gotto AM, for the AFCAPS/ TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS.JAMA

  • JR Downs, M Clearfield, +6 authors W Kruyer
  • 1998

Similar Papers

Loading similar papers…